Plenary Session 1 Genome Expression and Maintenance

DNA within chromatin regulates gene expression, influences cellular responses and is at the heart of cancer genetics and epigenetics. It is essential to understand how DNA and epigenetic alterations contribute to signaling pathways and impact treatment strategies. It also enables genomics to be exploited for precision medicine and biomarker discovery, making it an essential component of global cancer research.

  • John Diffley

    John Diffley

    The Francis Crick Institute

  • Mathieu Lupien

    Mathieu Lupien

    Ontario Institute for Cancer Research

  • Nada Jabado

    Nada Jabado

    McGill University

  • Jacques Côté

    Jacques Côté

    Centre de recherche du CHU de Québec-Université Laval

Plenary Session 2 Regulation by Coding and Non-Coding RNAs

RNA molecules, both coding and non-coding, play an essential role in modulating gene expression and influencing cell signaling pathways. Understanding the complex mechanisms by which RNA participates in cancer-related signaling events is essential to unravel the complexities of the disease. This session will explore emerging areas such as the impact of non-coding RNA on oncogenic pathways, potentially revealing new therapeutic targets and diagnostic markers. In addition, RNA-based technologies and therapies, such as mRNA vaccines, are gaining importance in cancer treatment, making it imperative to keep abreast of these advances as part of the symposium.

  • Nahum Sonenberg

    Nahum Sonenberg

    McGill University

  • Katherine Borden

    Katherine Borden

    Université de Montréal

  • Ly Vu

    Ly Vu

    BC Cancer Research

  • Martin Simard

    Martin Simard

    Centre de recherche du CHU de Québec-Université Laval

Plenary Session 3 Protein Dynamics and Cell Communications

Understanding the role of proteins and cellular communications in oncogenic pathways is fundamental to identifying therapeutic targets and biomarkers. In addition, targeted therapies often focus on the inhibition or modulation of specific proteins, making this session an integral part of advancing cancer treatment strategies.

  • Christian Landry

    Christian Landry

    Université Laval

  • Anne-Claude Gingras

    Anne-Claude Gingras

    Lunenfeld-Tanenbaum Research Institute

  • Marc Therrien

    Marc Therrien

    Université de Montréal

  • Nicolas Bisson

    Nicolas Bisson

    Centre de recherche du CHU de Québec-Université Laval

  • Elaine Fuchs

    Elaine Fuchs

    The Rockefeller University


-The Future in Cell Signaling Research

-Diversity of careers in cancer research (this part will be in French)

10 conférences éclair suivies d'un panel de discussion

Panel #1 : Carrières au public et parapublic

Panel #2 : Carrières au privé et entreprenariat

Powered by